Dr. Lisa A Kaiser, D.O. Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 441 S Livernois Rd, Ste 180, Rochester Hills, MI 48307 Phone: 248-652-2708 Fax: 248-652-0205 |
Ahmad Ghabsha, MD Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 75 Barclay Cir Ste 205, Rochester Hills, MI 48307 Phone: 248-651-6430 Fax: 248-650-1382 |
News Archive
Promedior, Inc., a clinical stage biotechnology company developing novel therapeutics for the treatment of fibrosis, today announced that principal investigator, Srdan Verstovsek, MD, PhD, will present interim data from the Company's ongoing Phase 2 clinical trial of its lead product candidate, PRM-151, for the treatment of myelofibrosis, in a poster presentation on June 2, 2014 at the American Society for Clinical Oncology 2014 Annual Meeting.
An analysis of previously uncharted chemical contents, mostly carbohydrates, in U.S.-consumed mushrooms shows that these fruity edible bodies of fungi could be tailored into dietary plans to help fill various nutritional needs.
Today, the Chan Zuckerberg Initiative committed $13.6 million to stand up a large-scale research collaboration between UC San Francisco, Stanford University, and the Chan Zuckerberg Biohub that aims to better understand the spread of COVID-19 across the San Francisco Bay Area.
The Department of Industrial Relations' Division of Workers' Compensation (DIR/DWC) is on target to implement a workers' compensation drug formulary by July of next year as required by Assembly Bill 1124.
Army scientists have developed the first lethal mouse model of SARS-CoV-2, the virus that causes COVID-19, using mice that were genetically engineered to express the human ACE2 gene-a key mechanism by which the virus enters human cells.
› Verified 8 days ago